pharmaceuticals
pharmaceuticals Articles
scPharmaceuticals Inc. (NASDAQ: SCPH) saw its shares drop massively on Wednesday after the firm announced that it had received a letter from the U.S. Food and Drug Administration. Essentially, the...
Published:
Last Updated:
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
Published:
Last Updated:
Pfizer shares were up marginally on Wednesday after the pharma giant announced that it would be committing over half a billion dollars to its venture capital arm.
Published:
Last Updated:
Verrica Pharmaceuticals expects to price 5 million shares in the range that results in an initial public offering valued up to $92 million.
Published:
Last Updated:
The 54th annual meeting of the American Society of Clinical Oncology (ASCO) has just concluded and there were some significant moves we saw as a result.
Published:
Last Updated:
Deciphera Pharmaceuticals saw its shares took a breather early Tuesday after the firm announced a secondary offering.
Published:
Last Updated:
Mylan saw its shares make a handy gain early on Tuesday after the FDA announced a key approval for Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim).
Published:
Last Updated:
Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from its early stage cancer study. The preliminary results...
Published:
Last Updated:
It’s no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many of the top companies are starting to apply...
Published:
Last Updated:
Pfizer announced early on Monday that it received a couple critical updates from the FDA related to its Xalkori (crizotinib).
Published:
Last Updated:
The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) shares dropped on Monday following a critical update from the U.S. Food and Drug Administration (FDA) on one of its subsidiaries. Essentially the agency...
Published:
Last Updated:
Nabriva Therapeutics watched its shares take a step back on Monday's despite seeing positive results in its late-stage pneumonia trial.
Published:
Last Updated:
This year marks the 54th annual meeting of the American Society of Clinical Oncology, the world’s largest clinical cancer conference.
Published:
Last Updated: